BRUIN CLL-313 showed significantly longer progression-free survival vs bendamustine plus rituximab, bringing a noncovalent BTK inhibitor to first-line care.
Press Release|Articles|July 3, 2025
Upcoming NCPA Items for Pharmacy Teams: July and August 2025
Listen
0:00 / 0:00
Key Takeaways
- NCPA is hosting events on pharmacy policy trends, Medicare enrollment, and diabetes education accreditation to support pharmacy teams.
- Advocacy efforts include engaging federal representatives to push for PBM reforms during the August in-district work period.
Advertisement
ALEXANDRIA, Va. (July 3, 2025) – The National Community Pharmacists Association is pleased to announce these upcoming events for pharmacists and pharmacy team members:
- July 24 – What States Did for Pharmacies in 2025, advocacy update. PBM reform, Medicaid managed care reform, and expanded scope of practice are abuzz in this year’s state legislative sessions! NCPA’s Joel Kurzman and Belawoe Akwakoku will unpack the momentum behind these impactful pharmacy policy trends.
Learn more and register. - July 31 – Medicare Transaction Facilitator Enrollment for Dispensing Entities webinar. During this NCPA-member only webinar, staff with the Centers for Medicare & Medicaid Services will provide a comprehensive explanation of the Medicare Transaction Facilitator process and will address questions from attendees.
Learn more and register.
- Aug. 24 – Registration deadline for the Diabetes Accreditation Boot Camp. The NCPA Innovation Center and PharmFurther offer this turnkey online course to help prepare participants for diabetes self-management education accreditation in six weeks or less so they can bill Medicare and other payers for diabetes education they’re probably already providing.
Learn more and register. - Ongoing –
- Encouraging community pharmacy teams to invite their federal representatives for a pharmacy visit during the August in-district work period. With PBM reforms falling out of the budget reconciliation bill, we need to continue pressing Congress to include previously agreed upon reforms. This important initiative will push for progress and keep community pharmacy on the minds of members of Congress.
Learn more and sign up to participate. - Registration is open for the Pre-Convention Growth and Profitability Programs being held in New Orleans ahead of the NCPA 2025 Annual Convention. Early bird rates are available for these programs through July 19.
Learn more and register. - Registration is open for the NCPA 2025 Annual Convention and Expo. The convention will be held Oct. 18-21 in New Orleans and is the premier national business show for independent pharmacists and their teams. Early bird rates are available for these programs through July 19.
Learn more and register.
- Encouraging community pharmacy teams to invite their federal representatives for a pharmacy visit during the August in-district work period. With PBM reforms falling out of the budget reconciliation bill, we need to continue pressing Congress to include previously agreed upon reforms. This important initiative will push for progress and keep community pharmacy on the minds of members of Congress.
Events are subject to change. Visit our website for the latest information on NCPA events.
Advertisement
Related to this article
A behavioral walking program matched supervised aerobic training for improving asthma control in a randomized trial of physically inactive adults.
Phase 2b data from EASD 2026 show the amylin-incretin combination also cut HbA1c by up to 2.9% in adults with obesity or overweight and type 2 diabetes.
American Pharmacists Month kicked off on October 1, honoring more than 700,000 pharmacy professionals and 250 years of caring for America's communities.
fMRI data show cagrilintide-semaglutide altered brain responses to high-calorie food cues; REIMAGINE analyses point to ectopic fat and bone effects.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
A Novo Nordisk–funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, although the findings cannot show causation.
Advertisement
Advertisement
Trending on Pharmacy Times
1
EloraTZP Delivers Up to 23.3% Weight Loss in Adults With Obesity and T2D
2
Pharmacists Key to Lp(a) Counseling and Lipid Optimization
3
Why Lp(a) Testing Lagged Behind LDL Cholesterol Screening
4
What the 2025-2030 Dietary Guidelines Mean for Heart Health
5